Body CompositionNCT07282119
Can EmeraldLED Reshape Your Body With Continued Use?
A study testing EmeraldLED in people with Body Composition, run by Efforia, Inc at 1 site in United States.
Trial summary
Already using EmeraldLED? TheGreen Light Therapy study explores how continuing participants' 15-minute sessions, twice a week, may continue to support positive changes in body composition. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Body Composition
- What is being tested?
- EmeraldLED
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 100 participants
- Where
- 1 siteUnited States
- Study dates
- 29 Aug 2025to 29 Aug 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Can read and understand English.
- US resident.
- Willing and able to follow the requirements of the protocol.
Who cannot join
- Individuals with eye conditions
- Individuals not active with EmeraldLED
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site, 1 recruiting
- Recruiting
Efforia
New York, New York, 10003
Matthew Amsden, (646) 679-2479, help@efforia.com
About this study
Already using EmeraldLED? TheGreen Light Therapy study explores how continuing participants' 15-minute sessions, twice a week, may continue to support positive changes in body composition.
Read the detailed description
This remotely administered decentralized trial is designed to rigorously explore the efficacy of green light therapy on body composition and overall well-being, under the leadership of Ryan, the CEO of beem® Light Sauna. With over 30 years of experience in the wellness industry, Ryan has observed firsthand the surge in popularity of green light therapy, accompanied by a myriad of claims regarding its benefits. Despite widespread anecdotal evidence suggesting that green light therapy can aid in weight loss and improve mood, there remains a significant gap in scientific research to support these claims conclusively. This study aims to bridge this gap by providing empirical evidence on the effects of green light therapy.
The objective of this study is to empower participants with knowledge about how green light exposure might influence their weight management efforts and overall sense of well-being. By participating in this remote trial, individuals will receive personalized data regarding changes in their body composition and mood, following a structured regimen of green light therapy. This personalized feedback will enable participants to make informed decisions about incorporating green light therapy into their health and wellness routines.
The significance of this study lies in its potential to challenge and possibly redefine existing weight management strategies. By collecting and analyzing data on how green light therapy affects individuals, this study seeks to provide insights that could lead to new, innovative approaches to health and wellness. While acknowledging the limitations of this initial trial, including the necessity for further comprehensive research, the findings could serve as a valuable foundation for future studies and health innovations.
In sum, this decentralized trial represents a critical step towards demystifying the effects of green light therapy on body composition and mood enhancement. Through rigorous scientific investigation, this study aims to validate or debunk the claims surrounding green light therapy, thereby contributing to the broader understanding of its potential benefits and limitations. Participants' involvement is not just a journey towards personal health enlightenment but also a contribution to the global conversation on effective, science-backed wellness strategies.
- Conditions
- Body Composition
- Being tested
- EmeraldLED
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
EmeraldLEDDevice
This device is a customizable, multi-wavelength therapeutic system designed for individualized cosmetic treatments. It features an easy-to-use interface with preprogrammed treatment categories, a wide pulsing frequency range from 1 to 15,000 Hz, and independent wavelength control for precise protocol tailoring. The system delivers five wavelengths-450 nm, 525 nm, 650 nm, 810 nm, and 980 nm-with an output power of 3,325 W and irradiance up to 119 mW/cm².
The green light EmeraldLED therapy provided in this study is set at 525 nm.
| Study group | Role | What they receive |
|---|---|---|
| Single arm where participants act as their own control | Experimental | Single Arm observational where participants act as their own control Receives: Device: EmeraldLED |
What is being measured
The primary outcome is the main question the study is designed to answer.
Body Composition Measurement Form
The Body Composition Measurement Form is specifically crafted to accurately track changes in body measurements relevant to individuals engaged in weight loss or bodybuilding. This form allows for the consistent recording of key physical metrics across various body parts, facilitating the evaluation of fitness progress. By using this form, individuals can obtain a clear picture of the physical changes resulting from their exercise routines and nutritional choices. Each measurement is to be recorded in centimeters to maintain uniformity and precision.
Measured: Change from baseline (Day 1-3) in body measurements at 4 weeks after the start of the intervention (Day 27-33).
Quality of Life and Health Survey
This survey asks about your feelings towards your quality of life, health, and various areas of your life. It covers your experiences and feelings in the past four weeks. Please choose the answer that appears most appropriate.
Measured: Change from baseline (Day 1-3) in quality of life and health perceptions at 4 weeks after the start of the intervention (Day 27-33).
Body Image and Self-Perception Survey
This survey aims to understand an individual's perception of their body, attractiveness, and physical functionality. It contains multiple-choice questions with five options ranging from 'Strongly Disagree' to 'Strongly Agree'. The questions are divided into three categories: Body Satisfaction, Attractiveness Evaluation, and Physical Functionality Awareness.
Measured: Change from baseline (Day 1-3) in body image and self-perception at 4 weeks after the start of the intervention (Day 27-33).
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted15 Dec 2025
- Study start29 Aug 2025
- Primary completion29 Aug 2026 (estimated)
- Study completion29 Aug 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Body CompositionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Not applicable
- Intervention model
- Single group
- Model description
- Single Arm observational where participants act as their own control
- Masking
- None (open label)
- Enrolment
- 100 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Efforia, Inc
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07282119
- Sponsor's protocol ID
- 44804
- Status last verified
- Dec 2025
- First submitted
- 5 Dec 2025
- Last updated
- 23 Dec 2025
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- Yes
Study at a glance
From the registry record, last updated by the sponsor on 23 Dec 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Can EmeraldLED Reshape Your Body With Continued Use?
- ClinicalTrials.gov ID
- NCT07282119
- Acronym / sponsor ID
- 44804
- Conditions
- Body Composition
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 100 participants (estimated)
- Lead sponsor
- Efforia, IncIndustry (pharma, biotech, devices)
- Study start
- 29 Aug 2025 (actual)
- Primary completion
- 29 Aug 2026 (estimated)
- Study completion
- 29 Aug 2026 (estimated)
- First posted
- 15 Dec 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Already using EmeraldLED? TheGreen Light Therapy study explores how continuing participants' 15-minute sessions, twice a week, may continue to support positive changes in body composition.
Detailed description
This remotely administered decentralized trial is designed to rigorously explore the efficacy of green light therapy on body composition and overall well-being, under the leadership of Ryan, the CEO of beem® Light Sauna. With over 30 years of experience in the wellness industry, Ryan has observed firsthand the surge in popularity of green light therapy, accompanied by a myriad of claims regarding its benefits. Despite widespread anecdotal evidence suggesting that green light therapy can aid in weight loss and improve mood, there remains a significant gap in scientific research to support these claims conclusively. This study aims to bridge this gap by providing empirical evidence on the effects of green light therapy.
The objective of this study is to empower participants with knowledge about how green light exposure might influence their weight management efforts and overall sense of well-being. By participating in this remote trial, individuals will receive personalized data regarding changes in their body composition and mood, following a structured regimen of green light therapy. This personalized feedback will enable participants to make informed decisions about incorporating green light therapy into their health and wellness routines.
The significance of this study lies in its potential to challenge and possibly redefine existing weight management strategies. By collecting and analyzing data on how green light therapy affects individuals, this study seeks to provide insights that could lead to new, innovative approaches to health and wellness. While acknowledging the limitations of this initial trial, including the necessity for further comprehensive research, the findings could serve as a valuable foundation for future studies and health innovations.
In sum, this decentralized trial represents a critical step towards demystifying the effects of green light therapy on body composition and mood enhancement. Through rigorous scientific investigation, this study aims to validate or debunk the claims surrounding green light therapy, thereby contributing to the broader understanding of its potential benefits and limitations. Participants' involvement is not just a journey towards personal health enlightenment but also a contribution to the global conversation on effective, science-backed wellness strategies.
Study design
- Primary purpose
- Health services research
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
- Model description
- Single Arm observational where participants act as their own control
| Arm | Type | Receives |
|---|---|---|
| Single arm where participants act as their own control | Experimental | Device: EmeraldLEDSingle Arm observational where participants act as their own control |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- Can read and understand English.
- US resident.
- Willing and able to follow the requirements of the protocol.
Key exclusion criteria (2 listed)
- Individuals with eye conditions
- Individuals not active with EmeraldLED
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| EmeraldLEDThis device is a customizable, multi-wavelength therapeutic system designed for individualized cosmetic treatments. It features an easy-to-use interface with preprogrammed treatment categories, a wide pulsing frequency range from 1 to 15,000 Hz, and independent wavelength control for precise protocol tailoring. The system delivers five wavelengths-450 nm, 525 nm, 650 nm, 810 nm, and 980 nm-with an output power of 3,325 W and irradiance up to 119 mW/cm². The green light EmeraldLED therapy provided in this study is set at 525 nm. | Device | Single arm where participants act as their own control |
Primary outcome
Body Composition Measurement Form
Time frame: Change from baseline (Day 1-3) in body measurements at 4 weeks after the start of the intervention (Day 27-33).
The Body Composition Measurement Form is specifically crafted to accurately track changes in body measurements relevant to individuals engaged in weight loss or bodybuilding. This form allows for the consistent recording of key physical metrics across various body parts, facilitating the evaluation of fitness progress. By using this form, individuals can obtain a clear picture of the physical changes resulting from their exercise routines and nutritional choices. Each measurement is to be recorded in centimeters to maintain uniformity and precision.
Quality of Life and Health Survey
Time frame: Change from baseline (Day 1-3) in quality of life and health perceptions at 4 weeks after the start of the intervention (Day 27-33).
This survey asks about your feelings towards your quality of life, health, and various areas of your life. It covers your experiences and feelings in the past four weeks. Please choose the answer that appears most appropriate.
Body Image and Self-Perception Survey
Time frame: Change from baseline (Day 1-3) in body image and self-perception at 4 weeks after the start of the intervention (Day 27-33).
This survey aims to understand an individual's perception of their body, attractiveness, and physical functionality. It contains multiple-choice questions with five options ranging from 'Strongly Disagree' to 'Strongly Agree'. The questions are divided into three categories: Body Satisfaction, Attractiveness Evaluation, and Physical Functionality Awareness.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 23 Dec 2025.
- Additional information and join instructions on EfforiaLink provided by the sponsor.
Related trials for Body Composition
Not yet recruiting
Effect of HMB Supplementation and Vivifrail Exercise on Body Composition, Handgrip Strength and Physical Performance in Women Over 60 Years of Age
Aging, Muscle Strength
Not yet recruitingObservational study
Clinical and Biological Parameters in Adolescent Idiopathic Scoliosis
Adolescent Idiopathic Scoliosis (AIS)
Recruiting
Digestion and Absorption of Postbiotic Regulatory Proteins
Protein Utilization
Not yet recruiting
Effects of the 11 for Health Program on Physical Fitness and Health-Related Outcomes in Schoolchildren
Physical Fitness, Health
RecruitingObservational study
A Natural History Study of Metabolic Sizing in Health and Disease
Metabolic Disorders, Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing EmeraldLED in people with Body Composition, run by Efforia, Inc at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 23 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Matthew Amsden (646-679-2479, help@efforia.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Body Composition Measurement Form (time frame: Change from baseline (Day 1-3) in body measurements at 4 weeks after the start of the intervention (Day 27-33).). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Dec 2025.